Study Warns: Increased COVID Vaccine Doses Linked to Higher Infection Risk
A recent study, led by Dr. Naabin Shrestha and collaborators, has raised concerns about the correlation between the number of COVID-19 vaccine doses administered and the risk of contracting the virus. The findings, published in a report from the Epoch Times, indicate that individuals who have received multiple vaccine doses face heightened susceptibility to COVID-19.
According to the report, individuals who received two doses of the COVID-19 vaccine exhibited a 1.5 times higher risk of contracting the virus. This risk increased to 1.95 times for those who received three doses and spiked to 2.5 times for individuals who received three or more doses. These figures were compared against individuals who received zero or only one dose of the vaccine.
The exact mechanisms behind this alarming trend remain unclear. Researchers speculate that vaccine-induced immunity might be weaker and less enduring compared to natural immunity. Consequently, while vaccination may offer some protection in the short term, it could potentially elevate the risk of future infections.
The Epoch Times highlighted this unsettling revelation, emphasizing the growing apprehension regarding the efficacy and safety of COVID-19 vaccines. Unlike traditional vaccines, which stimulate the body to develop resistance against pathogens, COVID-19 vaccines operate by triggering the production of a specific protein fragment found in the virus, purportedly eliciting a protective immune response.
Dr. Robert Malone, a prominent vaccine researcher not involved in the study, expressed concerns over the effectiveness of current COVID-19 vaccine products. He described the findings as another acknowledgment of their limited efficacy, suggesting that they might contribute to diminishing effectiveness over time.
Previous studies have also underscored potential adverse effects associated with COVID-19 vaccines, including the risk of fatal heart inflammation. Despite these concerns, the U.S. Centers for Disease Control and Prevention (CDC) continues to advocate for widespread vaccination, urging virtually everyone aged 6 months and older to receive multiple vaccine doses.
Dr. Harvey Risch, professor emeritus of epidemiology at Yale, offered insights into the potential mechanisms underlying the increased infection risk associated with multiple vaccine doses. He suggested that such doses might lead to antibody-dependent enhancement or “original antigenic sin,” diminishing the effectiveness of the antibody response generated by the initial vaccine dose.
